All In Biotech

Drug Trial Radar · NCT01107626

Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer

Randomized Phase III Study of Maintenance Therapy With Bevacizumab, Pemetrexed, or a Combination of Bevacizumab and Pemetrexed Following Carboplatin, Paclitaxel and Bevacizumab for Advanced Non-Squamous NSCLC

Last checked: Nov 20, 2026Latest source record: Jul 7, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 1,516 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,516

Actual

Start

Oct 25, 2010

Primary completion

Jan 31, 2019

Study completion Aug 17, 2021

Sponsor

Lead sponsor
ECOG-ACRIN Cancer Research GroupResearch network
Sponsor type
Research network
Collaborators
National Cancer Institute (NCI)
First posted
Apr 21, 2010

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

RATIONALE: Drugs used in chemotherapy, such as paclitaxel and carboplatin, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Monoclonal antibodies, such as bevacizumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find tumor cells and help kill them or carry tumor-killing substances to them. Bevacizumab may also stop the growth of non-small cell lung cancer by blocking blood flow to the tumor. Pemetrexed disodium may stop the growth of tumor cells by blocking some enzymes needed for cell growth. It is not yet known whether giving bevacizumab or pemetrexed disodium alone or in combination is more effective in treating non-squamous non-small cell lung cancer. PURPOSE: This randomized phase III trial is studying bevacizumab and pemetrexed disodium alone or in combination after induction therapy to see how well they work in treating patients with advanced non-squamous non-small cell lung cancer.

Conditions

  • Lung Cancer

Interventions

  • PaclitaxelDrug

    Given IV

  • CarboplatinDrug

    Given IV

  • BevacizumabBiological

    Given IV

  • Pemetrexed Disodium HeptahydrateDrug

    Given IV

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Overall SurvivalTime frame: Assessed every 6 weeks during induction therapy and every 3 cycles during maintenance therapy; after discontinuation of study therapy, assessed every 3 months for 2 years and every 6 months for years 3-5

Locations

434 sites in 1 country. Site status is shown where the registry gives one.

  • Regional Medical Center

    Anniston, Alabama

  • Fairbanks Cancer Treatment Center at Fairbanks Memorial Hospital

    Fairbanks, Alaska

  • North Bay Cancer Center

    Fairfield, California

  • Todd Cancer Institute at Long Beach Memorial Medical Center

    Long Beach, California

  • Community Hospital of the Monterey Peninsula Comprehensive Cancer Center

    Monterey, California

  • Veterans Affairs Medical Center - Palo Alto

    Palo Alto, California

  • Feather River Hospital Cancer Center

    Paradise, California

  • Sutter Cancer Center at Roseville Medical Center

    Roseville, California

  • Sutter Cancer Center

    Sacramento, California

  • Salinas Valley Memorial Hospital

    Salinas, California

  • Stanford Cancer Center

    Stanford, California

  • Aurora Presbyterian Hospital

    Aurora, Colorado

  • Boulder Community Hospital

    Boulder, Colorado

  • Penrose Cancer Center at Penrose Hospital

    Colorado Springs, Colorado

  • St. Anthony Central Hospital

    Denver, Colorado

  • Kaiser Permanente - Denver

    Denver, Colorado

  • Porter Adventist Hospital

    Denver, Colorado

  • Presbyterian - St. Luke's Medical Center

    Denver, Colorado

  • St. Joseph Hospital

    Denver, Colorado

  • Rose Medical Center

    Denver, Colorado

  • CCOP - Colorado Cancer Research Program

    Denver, Colorado

  • Swedish Medical Center

    Englewood, Colorado

  • Poudre Valley Hospital

    Fort Collins, Colorado

  • Front Range Cancer Specialists

    Fort Collins, Colorado

  • North Colorado Medical Center

    Greeley, Colorado

  • Kaiser Permanente - Lafayette

    Lafayette, Colorado

  • Littleton Adventist Hospital

    Littleton, Colorado

  • Sky Ridge Medical Center

    Lone Tree, Colorado

  • Hope Cancer Care Center at Longmont United Hospital

    Longmont, Colorado

  • McKee Medical Center

    Loveland, Colorado

  • Parker Adventist Hospital

    Parker, Colorado

  • St. Mary - Corwin Regional Medical Center

    Pueblo, Colorado

  • North Suburban Medical Center

    Thornton, Colorado

  • Exempla Lutheran Medical Center

    Wheat Ridge, Colorado

  • Praxair Cancer Center at Danbury Hospital

    Danbury, Connecticut

  • Helen and Harry Gray Cancer Center at Hartford Hospital

    Hartford, Connecticut

  • Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center

    Hartford, Connecticut

  • George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus

    New Britain, Connecticut

  • Kaiser Permanente at Capitol Hill Medical Center

    Washington D.C., District of Columbia

  • Sibley Memorial Hospital

    Washington D.C., District of Columbia

Showing 40 of 434 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.